Tissue factor (TF), a 47-kDa membrane-bound receptor (1, 2), has been used primarily as the target molecule for specific tumor therapy, because TF is specifically expressed in tumor vascular endothelial cells (VECs) and some types of malignant tumor cells (3–6). This evidence concerns the gene TF and cancer.